Comparative Study
doi: 10.1196/annals.1309.039.
Differential immune induction with subcutaneous versus oral administration of a diabetogenic insulin peptide in the NOD mouse
Affiliations
- PMID: 15681772
- DOI: 10.1196/annals.1309.039
Item in Clipboard
Comparative Study
Differential immune induction with subcutaneous versus oral administration of a diabetogenic insulin peptide in the NOD mouse
Ann N Y Acad Sci.
2004 Dec.
Abstract
The B chain insulin peptide 9 to 23 (B:9-23) is a dominant T cell epitope of the NOD mouse. Given in oral form with multiple different vehicles, it did not alter expression of insulin autoantibodies in contrast to subcutaneous administration.
Similar articles
-
Comparative study of oral versus subcutaneous B:9-23 insulin peptide in Balb/c mice as an experimental model for autoimmune diabetes.Ann N Y Acad Sci. 2004 Dec;1029:331-3. doi: 10.1196/annals.1309.038. Ann N Y Acad Sci. 2004. PMID: 15681773
-
Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes.J Autoimmun. 2004 Aug;23(1):17-26. doi: 10.1016/j.jaut.2004.03.008. J Autoimmun. 2004. PMID: 15236749
-
Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration.J Autoimmun. 1998 Apr;11(2):127-30. doi: 10.1006/jaut.1997.0184. J Autoimmun. 1998. PMID: 9650091
-
Insulin-specific tolerance in diabetes.Clin Immunol. 2002 Jan;102(1):2-11. doi: 10.1006/clim.2001.5142. Clin Immunol. 2002. PMID: 11781061 Review.
-
Insulin--a primary autoantigen in type 1 diabetes?Trends Mol Med. 2005 Oct;11(10):445-8. doi: 10.1016/j.molmed.2005.08.005. Trends Mol Med. 2005. PMID: 16150642 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
